Activation of early gene transcription in polyomavirus BK by human immunodeficiency virus type 1 Tat

J Gen Virol. 2006 Jun;87(Pt 6):1557-1566. doi: 10.1099/vir.0.81569-0.

Abstract

Polyomavirus BK (BKV) is a serious problem for immunocompromised patients, where latent virus can enter into the lytic cycle causing cytolytic destruction of host cells. BKV infects >80% of the population worldwide during childhood and then remains in a latent state in the kidney. In the context of immunosuppression in kidney transplant patients, reactivation of the viral early promoter (BKV(E)) results in production of T antigen, enabling virus replication and transition from latency to the lytic phase, causing polyomavirus-associated nephropathy. Reactivation of BKV can also cause complications such as nephritis, atypical retinitis and haemorrhagic cystitis in AIDS patients. Here, the effects of human immunodeficiency virus type 1 (HIV-1) proteins Tat and Vpr on BKV transcription were investigated and it was demonstrated that Tat dramatically stimulated BKV(E). Site-directed mutagenesis analysis of potential Tat-responsive transcriptional motifs complemented by an electrophoretic mobility shift assay (EMSA) showed that Tat activated BKV(E) by inducing binding of the NF-kappaB p65 subunit to a kappaB motif near the 3' end of BKV(E). In addition, a sequence within the 5' UTR of BKV(E) transcripts (BKV(E)-TAR) was identified that is identical to the HIV-1 transactivation response (TAR) element. The BKV(E)-TAR sequence bound TAT in RNA EMSA assays and deletion of the BKV(E)-TAR sequence eliminated Tat transactivation of BKV(E) transcription. Thus, Tat positively affected BKV(E) transcription by a dual mechanism and this may be important in diseases involving BKV reactivation in AIDS patients.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • BK Virus / pathogenicity*
  • BK Virus / physiology
  • Base Sequence
  • Cell Line
  • Gene Expression Regulation, Viral*
  • Gene Products, tat / metabolism*
  • Gene Products, vpr / metabolism
  • HIV-1 / metabolism
  • HeLa Cells
  • Humans
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • NF-kappa B / chemistry
  • NF-kappa B / metabolism
  • Promoter Regions, Genetic*
  • Transcription, Genetic*
  • Viral Proteins / genetics
  • Viral Proteins / metabolism
  • Virus Activation*
  • tat Gene Products, Human Immunodeficiency Virus
  • vpr Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, tat
  • Gene Products, vpr
  • NF-kappa B
  • Viral Proteins
  • tat Gene Products, Human Immunodeficiency Virus
  • vpr Gene Products, Human Immunodeficiency Virus